May 21, 2026 10:23AM
Apr 21, 2026 08:37AM
Apr 21, 2026 06:52AM
Mar 27, 2026 08:50AM
Mar 27, 2026 06:14AM
Mar 27, 2026 04:19AM
Mar 22, 2026 09:19PM Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
Mar 10, 2026 10:07PM
Mar 1, 2026 06:49PM
Feb 9, 2026 10:34PM
Feb 6, 2026 01:04AM
Feb 5, 2026 08:31PM
Jan 25, 2026 11:52PM
Jan 25, 2026 08:37PM FDA Accepts LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Jan 12, 2026 06:50PM
Jan 5, 2026 07:43PM
Nov 26, 2025 06:03AM
Nov 26, 2025 04:42AM
Nov 17, 2025 07:08AM
Oct 27, 2025 12:23AM
Oct 14, 2025 03:54AM LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
Oct 3, 2025 04:01AM
Sep 28, 2025 08:33PM
Sep 17, 2025 05:52AM
Sep 17, 2025 04:20AM
Sep 2, 2025 09:32PM
Sep 1, 2025 12:50AM
Aug 31, 2025 11:44PM FDA Approves LEQEMBI® IQLIKTM (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jul 30, 2025 07:20PM
Jul 30, 2025 07:10PM
Jul 16, 2025 12:50AM
May 21, 2025 01:00AM
Mar 4, 2025 02:22AM
Mar 2, 2025 10:53PM
Jan 27, 2025 06:46PM FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jan 14, 2025 07:03PM
Nov 14, 2024 11:31PM
Oct 31, 2024 11:56PM
Oct 30, 2024 11:56PM
Sep 5, 2024 02:59AM
Aug 22, 2024 05:54AM
Aug 13, 2024 07:59PM "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in the United Arab Emirates
Aug 5, 2024 11:15PM
Jul 30, 2024 11:59PM
Jul 11, 2024 10:56PM
Jul 10, 2024 08:00PM
Jun 28, 2024 01:57AM
Jun 10, 2024 04:50AM
May 28, 2024 01:19AM "LEQEMBI" Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea
May 23, 2024 04:07AM

322,940 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All